Filing Details
- Accession Number:
- 0001127602-20-007853
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-26 10:15:49
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-26 10:15:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-24 | 24,008 | $88.05 | 313,054 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-02-24 | 20,295 | $109.34 | 333,349 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-24 | 36,702 | $166.51 | 296,647 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-02-24 | 6,156 | $167.44 | 290,491 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-02-24 | 1,445 | $168.34 | 289,046 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-02-24 | 750 | $167.83 | 750 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2020-02-24 | 2,250 | $167.83 | 2,250 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-02-24 | 24,008 | $0.00 | 24,008 | $88.05 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-02-24 | 20,295 | $0.00 | 20,295 | $109.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,009 | 2018-02-24 | 2022-02-24 | No | 4 | M | Direct |
40,591 | 2019-02-23 | 2023-02-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 12,800 | Indirect | 2018 GRAT |
Common Stock | 25,000 | Indirect | 2019 GRAT |
Common Stock | 340 | Indirect | By Trust |
Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
- This transaction was executed in multiple trades at prices ranging from $166.035 to $167.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $167.05 to $167.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $168.08 to $169.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by trust of which the reporting person is trustee. The reporting person disclaims beneficial ownership of these securities.
- Held by trust of which the reporting person is trustee. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.